Monte Rosa Therapeutics GLUE Institutional Ownership

NASDAQ GLUE

$11.07 -0.15 (-1.29%)

As of: Oct 22, 2026 · 11:28 AM EDT

Institutions by Trading Activity

193 Institutions

Increased 110 57.0%

Unchanged 25 13.0%

Reduced 58 30.1%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

91.32%

▲+4.27 pp QoQ

Shares Held by Institutions

92.67Mn

of 101.48Mn outstanding

▲+6.58% QoQ

Shares Outstanding

101.48Mn

8.81Mn held outside 13F filers

Institutional Investors

193

filed 13F for Jun 2026

▲+3 vs prior quarter

Net Shares Added (QoQ)

+5.72Mn

accumulated since last quarter

Value of Holdings

$1.05Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Updated Oct 11, 2026

Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) was held by 193 institutional investors that filed 13F reports for the quarter ended June 30, 2026.

These investors held 91.32% of Monte Rosa Therapeutics' outstanding shares at the end of Q2 2026, up from 87.05% in Q1 2026.
Total holdings of Monte Rosa Therapeutics shares rose 6.58% from Q1 2026, and the number of holders rose 70.80% from Q2 2025.
Of these 193 holders, 110 added to their positions, 58 reduced their stakes and 25 left their positions unchanged.
Institutional investors held 92.67Mn shares of Monte Rosa Therapeutics in total at the end of Q2 2026, up 5.72Mn from the prior quarter and up 31.11Mn from a year earlier.
As of June 30, 2026, the biggest holder of Monte Rosa Therapeutics was T. Rowe Price Associates Inc with 8.86Mn shares, or 8.73% of shares outstanding.
Among existing holders, the largest additions to Monte Rosa Therapeutics in Q2 2026 came from T. Rowe Price Associates Inc (+2.14Mn shares), BlackRock, Inc. (+1.21Mn shares), Vestal Point Capital, LP (+996.53K shares), Woodline Partners LP (+888.39K shares) and Nextech Invest Ltd. (+456.92K shares).
The biggest cuts to GLUE positions during Q2 2026 came from American Century Companies Inc (-1.19Mn shares), Silverarc Capital Management, LLC (-893.75K shares), Braidwell LP (-755.01K shares), Montanova Capital, LLC (-677.27K shares) and Alphabet Inc. (-311.8K shares).
Business Quant data shows the 10 biggest positions in Monte Rosa Therapeutics as of Q2 2026 were held by T. Rowe Price Associates Inc (8.86Mn shares), NEA Management Company, LLC (7.69Mn shares), BlackRock, Inc. (6.84Mn shares), TCG Crossover Management, LLC (4.62Mn shares), Vestal Point Capital, LP (4.6Mn shares), BVF Inc (4.46Mn shares), Baker Bros. Advisors LP (4.35Mn shares), State Street Corp (3.73Mn shares), Montanova Capital, LLC (3.55Mn shares) and Vanguard Capital Management LLC (3.41Mn shares).

Form 13F Holdings

193 Institutional Holders

Report period 30 Jun, 2026

Total shares held 92.67Mn

Of outstanding 91.32%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	PRICE T ROWE ASSOCIATES INC /MD/	0000080255	8,861,171	8.73%	▲2,140,983	+31.86%	$214.44K
2	NEA Management Company, LLC	0001512848	7,692,298	7.58%	0	0.00%	$186.15Mn
3	BlackRock, Inc.	0002012383	6,843,087	6.74%	▲1,205,403	+21.38%	$165.60Mn
4	TCG Crossover Management, LLC	0001839948	4,622,151	4.55%	0	0.00%	$111.86Mn
5	Vestal Point Capital, LP	0001974915	4,600,000	4.53%	▲996,535	+27.65%	$111.32Mn
6	BVF INC/IL	0001056807	4,460,886	4.40%	0	0.00%	$107.95Mn
7	BAKER BROS. ADVISORS LP	0001263508	4,345,736	4.28%	0	0.00%	$105.17Mn
8	State Street Corp	0000093751	3,731,416	3.68%	▲377,436	+11.25%	$90.30Mn
9	MONTANOVA CAPITAL, LLC	0001569064	3,549,539	3.50%	▼677,270	-16.02%	$85.90Mn
10	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	3,412,927	3.36%	▲312,682	+10.09%	$82.59Mn
11	Versant Venture Management, LLC	0001560009	3,180,780	3.13%	0	0.00%	$76.97Mn
12	BRAIDWELL LP	0001920938	2,451,562	2.42%	▼755,012	-23.55%	$59.33Mn
13	GEODE CAPITAL MANAGEMENT, LLC	0001214717	1,864,113	1.84%	▲323,301	+20.98%	$45.12Mn
14	AMERICAN CENTURY COMPANIES INC	0000748054	1,622,846	1.60%	▼1,186,801	-42.24%	$39.27Mn
15	MARSHALL WACE, LLP	0001318757	1,593,600	1.57%	▲160,448	+11.20%	$38.57Mn
16	Aisling Capital Management LP	0001766721	1,555,664	1.53%	0	0.00%	$37.65Mn
17	Bellevue Group AG	0001674546	1,190,000	1.17%	▼60,000	-4.80%	$28.80Mn
18	DIMENSIONAL FUND ADVISORS LP	0000354204	1,177,488	1.16%	▲136,116	+13.07%	$28.49Mn
19	MPM BioImpact LLC	0001687078	1,161,081	1.14%	▼15,847	-1.35%	$28.10Mn
20	SILVERARC CAPITAL MANAGEMENT, LLC	0001816307	1,108,295	1.09%	▼893,745	-44.64%	$26.82Mn

Showing 1 to 20 of 193 holders